Building a European Strategy of Biomedical Research into myalgic encephalomyelitis

The European ME Research Group (EMERG) is a network of European researchers and researcher-clinicians who formed to collaborate and share knowledge in research into myalgic encephalomyelitis (ME, sometimes referred to as ME/CFS).
The group was formed in 2015 to create a strategy of high-quality, coordinated biomedical research that would allow accumulation of data based on collaboration and sharing of experiences and knowledge, and aid identification of areas of research to form this strategy.
This assists in expanding the capacity of research in Europe leading to progress in developing a rapid pathway for discovering the cause(s) of, and treatment(s) for, ME.

The development of new research and the accumulation of shared data based on collaboration and experiences allows more rapid progress in the building of a foundation of fundamental research into ME in Europe.

The group also supports emerging talent through Young EMERG, a network for early-career researchers. Working alongside the European ME clinicians Council and patient groups in the European ME Alliance (EMEA),

EMERG aims to accelerate progress in ME research by combining scientific expertise, clinical practice, and patient advocacy.

Click on image above

ME - What it IS…

Myalgic Encephalomyelitis (ME, sometimes referred to as ME/CFS) is a serious, acquired, chronic, complex, and systemic disease associated with neurological, immunological, autonomic, and energy metabolism dysfunction (Institute of Medicine, 2015). Individuals with ME/CFS experience a range of symptoms including significant impairment in function, post-exertional malaise, sleep impairment, cognitive issues, pain, orthostatic intolerance, flu-like symptoms, sensory intolerance, gastrointestinal and genitourinary issues.

ME has been classified as a neurological disorder in the World Health Organisation's International Classification of Diseases under Postviral Fatigue Syndrome (PVFS) since 1969 (WHO code ICD 10 G93.3).
Since 1992, the term "Chronic Fatigue Syndrome" (CFS) has been included in the Alphabetical Index and indexed to G93.3
In ICD-11, myalgic encephalomyelitis (ME) and chronic fatigue syndrome are classified under Chapter 8: Diseases of the Nervous System, within the code 8E49 Postviral fatigue syndrome.

To date there is no known and universally accepted, specific medical diagnostic test to determine or confirm a correct diagnosis nor is there any specific treatment for this condition.
The cause(s) of ME are unknown, but many individuals with the disease remain ill after an acute infection with symptoms that persist for six or more months.
There is currently no universally accepted diagnostic test or approved treatment for ME.


EMERG team

Details of the members participating in EMERG from across Europe

Current News Items

A summary of recent and current news.
These include news items concerning EMERG researchers and clinicians, also Young EMERG and early career topics and relevant news from the European ME Alliance.
The expertise of EMERG members means that the group can be a powerful influence when research expertise is required at conferences and educational events.

A symposium in Belgrade with EMERG researchers participating

Read more

New members of EMERG are announced and an update on the EMERG application

Read more

Next year's Young EMERG workshop will now be spread over two days during the International ME Conference Week

Read more

Recent/Upcoming Events

Upcoming and recent events involving EMERG, Young EMERG and EMEA.
These included workshops and conferences.
The expertise of EMERG members means that the group can be a powerful influence when research expertise is required at conferences and educational events.

European ME Research Group meets in Cambridge, UK, Read more
The European ME Research Group (Young EMERG) - a network of young or early career researchers for ME - will hold its annual international workshop A meeting will be held on 26-27 May in Cambridge, UK, with international delegates. Read more
#BRMEC14 - the fourteenth International Biomedical Research into ME Colloquium - held in UK by UK charity Invest in ME Research - on 28th - 30th May 2025 - with chairing and input from EMERG More details here.

Comments on EMERG

contact us

Contact Us


Contact us using the link below.

Contact Us